{"id":"W2803252171","doi":"10.2146/ajhp170707","title":"Proprotein convertase subtilisin/kexin type 9 inhibitors for reduction of cardiovascular events","year":2018,"lang":"en","type":"review","venue":"American Journal of Health-System Pharmacy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"","keywords":"Evolocumab; Alirocumab; PCSK9; Kexin; Medicine; Proprotein convertase; Pharmacology; Placebo; Adverse effect; Familial hypercholesterolemia; Internal medicine; Cholesterol; LDL receptor; Lipoprotein","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007781232,0.0006337677,0.007843776,0.0006946155,0.0001750459,0.00001538792,0.0003593261,0.0001485542,0.000015493],"category_scores_gemma":[0.0002052134,0.0004691599,0.004778035,0.0009291279,0.0002500934,0.0001432264,0.00005204709,0.0007774475,0.00001814794],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001264325,"about_ca_system_score_gemma":0.006774012,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001427191,"about_ca_topic_score_gemma":0.000001168319,"domain_scores_codex":[0.9914354,0.001880132,0.00385578,0.0005725663,0.001565095,0.0006909965],"domain_scores_gemma":[0.9907922,0.00008523987,0.005682156,0.001055399,0.001692094,0.0006929677],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004673457,0.0001508804,0.000007206629,0.09273108,0.005114992,0.00003964869,0.0001286503,0.000001863638,0.000003528399,0.000004481204,0.001357295,0.899993],"study_design_scores_gemma":[0.002744725,0.003247455,0.000003203348,0.0420124,0.005445509,0.005522723,0.0003255814,0.000006413762,0.0001208916,0.000001787054,0.9402629,0.000306418],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008233676,0.9896101,0.0006359694,0.0004158241,0.002568441,0.00580615,0.00008035662,0.00003488896,0.00002490221],"genre_scores_gemma":[0.007607039,0.9864251,0.001449647,0.00005943866,0.004012327,0.0001620532,0.00005480577,0.0001796626,0.00004994987],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9389056,"threshold_uncertainty_score":0.999776,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06068419422584077,"score_gpt":0.3784755663729056,"score_spread":0.3177913721470649,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}